Equities

Terragen Holdings Ltd

TGH:ASX

Terragen Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.014
  • Today's Change0.00 / 0.00%
  • Shares traded265.69k
  • 1 Year change-48.15%
  • Beta-0.1428
Data delayed at least 20 minutes, as of Jun 14 2024 06:37 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Terragen Holdings Limited is an agricultural biological company. The Company is specializing in the application of microbial technology. The Company conducts research activities for the advancement of the use of probiotics in agricultural applications. Research is focused on determining the optimum combination and concentration of naturally occurring live microbe strains to help boost the productivity, welfare and resilience of farm production animals and address soil health. The Company has two products on the market in Australia and New Zealand: a microbial feed supplement for animals known as Mylo, and a soil conditioner called Great Land Plus. Mylo is an easy-to-use liquid feed supplement for dairy calves and cows that contains a specialized selection and blend of live microbes. Great Land Plus helps farmers enhance soil characteristics, making nutrients more available to plants. It may also improve yield by changing the soil microbiome and enhancing root development.

  • Revenue in AUD (TTM)2.60m
  • Net income in AUD-2.53m
  • Incorporated1996
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hydration Pharmaceuticals Co Ltd15.13m-12.21m3.05m--------0.2015-0.0626-0.06260.0776-0.0021.181.616.60---94.86-79.98-143.75-111.5753.7048.73-80.69-99.531.37-21.481.10--10.3419.2723.61------
Bod Science Ltd3.32m-7.95m4.26m--------1.28-0.0557-0.05570.0235-0.00460.75332.428.05---180.40-94.62-465.66-145.7769.2347.08-239.47-129.480.8319--3.71---34.7023.20-47.10--8.23--
Cambium Bio Ltd-28.22k-366.01k4.60m-----------0.0012-0.0012-0.00009-0.0036-0.039-------50.58-49.44---292.47-------118.34------------60.86------
Zelira Therapeutics Ltd1.62m-36.43m4.99m8.00------3.08-3.23-3.230.148-0.20630.08480.1853.55---193.14-27.71-243.04-28.8182.28---2,278.17-508.480.1488-22.80-----80.95-0.363553.35------
Terragen Holdings Ltd2.60m-2.53m5.17m----0.7559--1.98-0.0099-0.00990.01010.01850.33640.575811.93---32.71-43.86-39.59-50.1196.6187.96-97.24-173.815.79-347.500.0587--13.6731.2240.19---12.30--
Invex Therapeutics Ltd837.95k-6.01m5.26m----0.9934--6.28-0.08-0.080.01120.07050.0521--2.79---37.38---40.06-------717.76------0.00--379.22---96.04------
Neuroscientific Biopharmaceuticals Ltd3.94m761.17k5.78m--7.411.526.961.470.00540.00540.02730.02641.02--76.13--19.64-55.7223.29-60.89----19.34-301.54--54.640.00--7,292.97179.9789.76------
Vectus Biosystems Ltd86.39k-2.49m6.12m----2.58--70.83-0.0467-0.04670.00160.04450.0191-------54.95-96.22-68.14-691.17-----2,880.80-27,693.78---439.760.00--69,287.5097.8713.64------
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
Island Pharmaceuticals Ltd10.28k-2.37m7.28m----9.03--707.69-0.026-0.0260.00010.0070.0038--0.0318---88.77---134.02-------23,100.68------0.4433-------8.58------
Anatara Lifesciences Ltd0.00-1.75m7.65m----5.30-----0.014-0.0140.000.00760.00-------103.15-59.64-115.72-66.52-------1,927.05----0.00------20.10---40.49--
Data as of Jun 14 2024. Currency figures normalised to Terragen Holdings Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.